Regulations.gov document
Microbiology Devices; Reclassification of Certain Hepatitis C Virus Antibody Assay…
Rule · FDA-2020-N-1082 · posted Nov 22, 2021
Key facts
| Document ID | FDA-2020-N-1082-0018 |
|---|---|
| Title | Microbiology Devices; Reclassification of Certain Hepatitis C Virus Antibody Assay Devices, Renamed to Hepatitis C Virus Antibody Tests |
| Document type | Rule |
| Subtype | Final Rule |
| Agency | FDA |
| Docket | FDA-2020-N-1082 |
| Posted | Nov 22, 2021 |
| Federal Register citation | 86 FR 66173 |
| FR document number | 2021-25374 |
| CFR | 21 CFR Part 866 |
| Comment period opens | Nov 22, 2021 |
At a glance
- 1–9 Pages
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: